评论:托尔瓦普坦用于自身主导多囊性病 (ADPKD) - 一个更新
Matt Gittus1,2, Helen Haley3, Tess Harris4
1University of Sheffield, Sheffield, United Kingdom. mjgittus1@sheffield.ac.uk.
BMC nephrology
|February 14, 2025
概括
自体主导多囊性病 (ADPKD) 影响了英国的许多人,往往导致末期病 (ESKD). 本指南为医疗保健专业人员提供了实际的,最新的建议,以改善ADPKD患者的护理.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 遗传学 遗传学 是一个
- 内部医学 内部医学
背景情况:
- 自体主导多囊性病 (ADPKD) 是英国末期病 (ESKD) 的主要遗传原因,影响约7万个人.
- 以双边脏和肝脏囊为特征,ADPKD是一种多系统性疾病,对生活质量产生重大影响,包括疼痛,疲劳和情绪困扰.
- 托尔瓦普坦提供了向治疗,将ADPKD管理转移到一般慢性病方法之外,但实际的临床指导仍然不足.
研究的目的:
- 为英国医疗保健专业人员提供最新的,实用的指导,以管理自身主导性多囊性病 (ADPKD).
- 通过结合新的证据,现实世界的数据和专家意见,扩大之前的英国脏协会 (UKKA) 建议.
- 将患者的观点纳入临床建议,以协调整个英国的ADPKD护理.
主要方法:
- 审查和综合与ADPKD管理相关的最新证据库.
- 结合现实世界的数据和专家临床意见.
- 与受ADPKD影响的个人共同制定建议.
主要成果:
- 该评论为ADPKD管理提供了最新的证据基础.
- 它包括基于现实数据和专家共识的实际建议.
- 整合了患者的观点,以提高指南的相关性和适用性.
结论:
- 现有的指南需要加强,为医疗保健专业人员在现实世界ADPKD护理中提供全面的实际支持.
- 本更新的评论旨在弥合一般指导方针与实际临床应用之间的差距.
- 这些建议旨在提高护理质量,并协调英国所有ADPKD患者的治疗.
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
2.6K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.6K
Renal Drug Excretion: Overview
1.1K
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
1.1K
Renal Drug Excretion: Tubular Reabsorption
1.2K
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
1.2K
Renal Drug Clearance: Overview
1.1K
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
1.1K
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
371
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
371
Acute Kidney Injury IV: Diagnostic Studies and Prevention
559
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
559


